Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Exelixis, Inc. (EXEL) since 2002 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Exelixis, Inc.. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 939767.
Total stock buying since 2002: $19,172,979.
Total stock sales since 2002: $314,392,814.
Total stock option exercises since 2002: $121,154,617.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 735,666 | $30,976,923 | 832,087 | $16,164,336 |
| 2024 | 615,000 | $12,666,910 | 872,432 | $24,870,534 | 1,184,849 | $27,369,242 |
| 2023 | 120,409 | $2,602,038 | 790,011 | $15,720,431 | 955,000 | $12,029,098 |
| 2022 | 0 | $0 | 436,562 | $8,413,845 | 525,000 | $2,574,050 |
| 2021 | 0 | $0 | 1,335,658 | $29,298,416 | 1,610,000 | $5,472,649 |
| 2020 | 0 | $0 | 2,145,329 | $47,948,063 | 4,262,623 | $19,133,251 |
| 2019 | 0 | $0 | 2,360,470 | $50,493,429 | 1,819,929 | $9,680,173 |
| 2018 | 0 | $0 | 1,561,698 | $32,260,917 | 1,448,858 | $7,586,210 |
| 2017 | 0 | $0 | 2,246,867 | $53,251,678 | 1,895,509 | $9,574,264 |
| 2016 | 60,000 | $297,920 | 795,219 | $11,897,846 | 1,152,332 | $8,539,362 |
| 2015 | 100,000 | $488,549 | 352,425 | $2,055,775 | 357,633 | $1,984,151 |
| 2014 | 20,000 | $34,200 | 0 | $0 | 23,914 | $0 |
| 2013 | 10,000 | $51,400 | 0 | $0 | 54,270 | $0 |
| 2012 | 35,000 | $156,795 | 7,000 | $35,917 | 54,271 | $0 |
| 2011 | 0 | $0 | 0 | $0 | 121,327 | $0 |
| 2010 | 482,700 | $1,489,754 | 108,539 | $835,207 | 104,427 | $570,120 |
| 2009 | 0 | $0 | 33,835 | $208,447 | 12,500 | $63,000 |
| 2008 | 392,500 | $1,276,125 | 27,213 | $188,239 | 0 | $0 |
| 2007 | 0 | $0 | 119,375 | $1,276,190 | 0 | $0 |
| 2006 | 0 | $0 | 205,624 | $2,114,980 | 65,624 | $414,711 |
| 2005 | 0 | $0 | 325,458 | $2,545,977 | 0 | $0 |
| 2004 | 10,000 | $85,388 | 0 | $0 | 0 | $0 |
| 2002 | 2,000 | $23,900 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2020-02-26 | Morrissey Michael (President and CEO) | Sale | 25,000 | 19.25 | 481,250 |
| 2020-02-26 | Morrissey Michael (President and CEO) | Option Ex | 25,000 | 5.51 | 137,750 |
| 2020-02-19 | Haley Patrick J. (EVP, Commercial) | Sale | 5,000 | 22.00 | 110,000 |
| 2020-02-19 | Haley Patrick J. (EVP, Commercial) | Option Ex | 5,000 | .00 | 0 |
| 2020-02-19 | Schwab Gisela (Pres, Prod Dev & Med Aff & CMO) | Sale | 40,000 | 21.50 | 860,000 |
| 2020-02-19 | Schwab Gisela (Pres, Prod Dev & Med Aff & CMO) | Option Ex | 40,000 | 5.51 | 220,400 |
| 2020-02-19 | Morrissey Michael (President and CEO) | Sale | 25,000 | 21.75 | 543,750 |
| 2020-02-19 | Morrissey Michael (President and CEO) | Option Ex | 25,000 | .00 | 0 |
| 2020-02-18 | Scangos George A | Sale | 50,000 | 20.73 | 1,036,500 |
| 2020-02-14 | Garber Alan M | Sale | 12,500 | 21.02 | 262,750 |
| 2020-02-13 | Morrissey Michael (President and CEO) | Sale | 25,000 | 20.11 | 502,750 |
| 2020-02-13 | Morrissey Michael (President and CEO) | Option Ex | 25,000 | 5.51 | 137,750 |
| 2020-02-12 | Scangos George A | Sale | 21,000 | 20.02 | 420,420 |
| 2020-02-11 | Scangos George A | Sale | 4,000 | 20.14 | 80,560 |
| 2020-02-07 | Schwab Gisela (Pres, Prod Dev & Med Aff & CMO) | Sale | 50,000 | 18.37 | 918,500 |
| 2020-02-07 | Schwab Gisela (Pres, Prod Dev & Med Aff & CMO) | Option Ex | 50,000 | 5.51 | 275,500 |
| 2020-01-29 | Morrissey Michael (President and CEO) | Sale | 25,000 | 17.87 | 446,750 |
| 2020-01-29 | Morrissey Michael (President and CEO) | Option Ex | 25,000 | 5.51 | 137,750 |
| 2020-01-23 | Morrissey Michael (President and CEO) | Sale | 25,000 | 19.41 | 485,250 |
| 2020-01-23 | Morrissey Michael (President and CEO) | Option Ex | 25,000 | 5.51 | 137,750 |
| 2020-01-22 | Scangos George A | Sale | 25,000 | 19.75 | 493,750 |
| 2020-01-16 | Morrissey Michael (President and CEO) | Sale | 25,000 | 20.33 | 508,249 |
| 2020-01-16 | Morrissey Michael (President and CEO) | Option Ex | 25,000 | 5.51 | 137,750 |
| 2020-01-15 | Scangos George A | Sale | 25,000 | 20.39 | 509,750 |
| 2020-01-15 | Marchesi Vincent T | Sale | 61,683 | 20.01 | 1,234,276 |
| 2020-01-08 | Morrissey Michael (President and CEO) | Sale | 25,000 | 18.85 | 471,250 |
| 2020-01-08 | Morrissey Michael (President and CEO) | Option Ex | 25,000 | 5.51 | 137,750 |
| 2020-01-07 | Garber Alan M | Sale | 86,956 | 18.01 | 1,566,077 |
| 2020-01-07 | Garber Alan M | Option Ex | 86,956 | 5.20 | 452,171 |
| 2020-01-07 | Schwab Gisela (Pres, Prod Dev & Med Aff & CMO) | Sale | 50,000 | 17.96 | 898,000 |
| 2020-01-07 | Schwab Gisela (Pres, Prod Dev & Med Aff & CMO) | Option Ex | 50,000 | 5.51 | 275,500 |
| 2020-01-02 | Morrissey Michael (President and CEO) | Sale | 25,000 | 17.49 | 437,249 |
| 2020-01-02 | Morrissey Michael (President and CEO) | Option Ex | 25,000 | 5.51 | 137,750 |
| 2019-12-27 | Scangos George A | Sale | 25,000 | 18.25 | 456,250 |
| 2019-12-03 | Schwab Gisela (Pres, Prod Dev & Med Aff & CMO) | Sale | 50,000 | 16.22 | 811,000 |
| 2019-12-03 | Schwab Gisela (Pres, Prod Dev & Med Aff & CMO) | Option Ex | 50,000 | 5.51 | 275,500 |
| 2019-11-04 | Schwab Gisela (Pres, Prod Dev & Med Aff & CMO) | Sale | 50,000 | 15.99 | 799,500 |
| 2019-11-04 | Schwab Gisela (Pres, Prod Dev & Med Aff & CMO) | Option Ex | 50,000 | 5.51 | 275,500 |
| 2019-10-10 | Haley Patrick J. (Sr. Vice President, Commercial) | Sale | 303 | 16.27 | 4,929 |
| 2019-10-02 | Morrissey Michael (President and CEO) | Sale | 26,364 | 17.66 | 465,588 |
| 2019-10-02 | Morrissey Michael (President and CEO) | Option Ex | 35,409 | 7.18 | 254,236 |
| 2019-10-01 | Schwab Gisela (Pres, Prod Dev & Med Aff & CMO) | Sale | 30,000 | 17.87 | 536,100 |
| 2019-10-01 | Schwab Gisela (Pres, Prod Dev & Med Aff & CMO) | Option Ex | 30,000 | 5.51 | 165,300 |
| 2019-09-18 | Morrissey Michael (President and CEO) | Sale | 37,227 | 19.20 | 714,758 |
| 2019-09-18 | Morrissey Michael (President and CEO) | Option Ex | 50,000 | 7.18 | 359,000 |
| 2019-09-10 | Haley Patrick J. (Sr. Vice President, Commercial) | Sale | 1,000 | 18.84 | 18,840 |
| 2019-08-16 | Hessekiel Jeffrey (EVP and General Counsel) | Sale | 75,000 | 21.10 | 1,582,500 |
| 2019-08-16 | Hessekiel Jeffrey (EVP and General Counsel) | Option Ex | 75,000 | 1.70 | 127,500 |
| 2019-08-16 | Poste George | Sale | 25,000 | 20.50 | 512,500 |
| 2019-08-16 | Poste George | Option Ex | 25,000 | 4.58 | 114,500 |
| 2019-08-14 | Morrissey Michael (President and CEO) | Sale | 35,040 | 20.11 | 704,654 |
| 2019-08-14 | Morrissey Michael (President and CEO) | Option Ex | 50,000 | 7.18 | 359,000 |
| 2019-08-12 | Haley Patrick J. (Sr. Vice President, Commercial) | Sale | 1,000 | 20.39 | 20,390 |
| 2019-08-09 | Poste George | Sale | 20,000 | 20.60 | 412,000 |
| 2019-08-09 | Poste George | Option Ex | 20,000 | 5.25 | 105,000 |
| 2019-08-06 | Haley Patrick J. (Sr. Vice President, Commercial) | Sale | 25,000 | 20.02 | 500,500 |
| 2019-08-06 | Haley Patrick J. (Sr. Vice President, Commercial) | Option Ex | 25,000 | 1.70 | 42,500 |
| 2019-08-02 | Morrissey Michael (President and CEO) | Sale | 35,040 | 20.25 | 709,560 |
| 2019-08-02 | Morrissey Michael (President and CEO) | Option Ex | 50,000 | 7.18 | 359,000 |
| 2019-08-01 | Scangos George A | Sale | 40,000 | 20.86 | 834,200 |
| 2019-07-17 | Morrissey Michael (President and CEO) | Sale | 34,721 | 21.37 | 741,987 |
| 2019-07-17 | Morrissey Michael (President and CEO) | Option Ex | 50,000 | 7.18 | 359,000 |
| 2019-07-10 | Haley Patrick J. (Sr. Vice President, Commercial) | Sale | 1,000 | 20.96 | 20,960 |
| 2019-07-03 | Morrissey Michael (President and CEO) | Sale | 34,721 | 21.03 | 730,182 |
| 2019-07-03 | Morrissey Michael (President and CEO) | Option Ex | 50,000 | 7.18 | 359,000 |
| 2019-07-01 | Scangos George A | Sale | 40,000 | 21.58 | 863,199 |
| 2019-06-19 | Lamb Peter (EVP, Scientific Strategy & CSO) | Option Ex | 17,404 | 5.51 | 95,896 |
| 2019-06-18 | Lamb Peter (EVP, Scientific Strategy & CSO) | Sale | 100,000 | 20.67 | 2,067,000 |
| 2019-06-18 | Lamb Peter (EVP, Scientific Strategy & CSO) | Option Ex | 100,000 | 3.60 | 360,500 |
| 2019-06-17 | Lamb Peter (EVP, Scientific Strategy & CSO) | Sale | 117,404 | 20.62 | 2,421,457 |
| 2019-06-17 | Lamb Peter (EVP, Scientific Strategy & CSO) | Option Ex | 100,000 | 3.63 | 363,000 |
| 2019-06-13 | Lamb Peter (EVP, Scientific Strategy & CSO) | Sale | 27,596 | 20.03 | 552,747 |
| 2019-06-13 | Lamb Peter (EVP, Scientific Strategy & CSO) | Option Ex | 27,596 | 5.56 | 153,433 |
| 2019-06-10 | Haley Patrick J. (Sr. Vice President, Commercial) | Sale | 1,000 | 20.23 | 20,230 |
| 2019-06-04 | Scangos George A | Sale | 15,000 | 20.00 | 300,000 |
| 2019-06-03 | Scangos George A | Sale | 25,000 | 19.61 | 490,250 |
| 2019-05-29 | Morrissey Michael (President and CEO) | Option Ex | 14,591 | 7.18 | 104,763 |
| 2019-05-21 | Scangos George A | Option Ex | 15,000 | 4.57 | 68,550 |
| 2019-05-10 | Haley Patrick J. (Sr. Vice President, Commercial) | Sale | 1,000 | 19.58 | 19,580 |
| 2019-05-08 | Willsey Lance | Sale | 50,000 | 20.36 | 1,018,000 |
| 2019-05-08 | Morrissey Michael (President and CEO) | Sale | 42,000 | 20.15 | 846,299 |
| 2019-05-08 | Morrissey Michael (President and CEO) | Option Ex | 42,000 | 5.56 | 233,519 |
| 2019-05-03 | Senner Christopher J. (EVP and CFO) | Sale | 36,261 | 20.70 | 750,602 |
| 2019-05-02 | Scangos George A | Sale | 15,000 | 20.00 | 300,000 |
| 2019-05-01 | Scangos George A | Sale | 25,000 | 19.75 | 493,750 |
| 2019-04-24 | Morrissey Michael (President and CEO) | Sale | 40,000 | 20.75 | 830,000 |
| 2019-04-24 | Morrissey Michael (President and CEO) | Option Ex | 40,000 | 5.56 | 222,399 |
| 2019-04-10 | Haley Patrick J. (Sr. Vice President, Commercial) | Sale | 1,000 | 24.04 | 24,040 |
| 2019-04-10 | Morrissey Michael (President and CEO) | Sale | 40,000 | 24.06 | 962,400 |
| 2019-04-10 | Morrissey Michael (President and CEO) | Option Ex | 40,000 | 5.56 | 222,399 |
| 2019-04-03 | Schwab Gisela (Pres, Prod Dev & Med Aff & CMO) | Sale | 63,109 | 25.00 | 1,577,725 |
| 2019-04-03 | Schwab Gisela (Pres, Prod Dev & Med Aff & CMO) | Option Ex | 63,109 | 7.18 | 453,122 |
| 2019-04-03 | Scangos George A | Sale | 5,000 | 25.03 | 125,150 |
| 2019-04-01 | Hessekiel Jeffrey (EVP and General Counsel) | Sale | 20,000 | 24.03 | 480,600 |
| 2019-04-01 | Hessekiel Jeffrey (EVP and General Counsel) | Option Ex | 20,000 | 1.70 | 34,000 |
| 2019-04-01 | Garber Alan M | Sale | 30,000 | 23.98 | 719,550 |
| 2019-04-01 | Garber Alan M | Option Ex | 30,000 | 5.25 | 157,350 |
| 2019-04-01 | Scangos George A | Sale | 40,000 | 24.02 | 960,800 |
| 2019-04-01 | Wyszomierski Jack L | Sale | 7,822 | 23.97 | 187,493 |
| 2019-04-01 | Wyszomierski Jack L | Option Ex | 26,250 | 4.37 | 114,581 |
| 2019-03-29 | Poste George | Sale | 3,860 | 23.89 | 92,215 |
| 2019-03-29 | Poste George | Option Ex | 15,000 | 4.57 | 68,550 |
| 2019-03-27 | Morrissey Michael (President and CEO) | Sale | 40,000 | 23.39 | 935,600 |
| 2019-03-27 | Morrissey Michael (President and CEO) | Option Ex | 40,000 | 5.56 | 222,399 |
| 2019-03-26 | Haley Patrick J. (Sr. Vice President, Commercial) | Sale | 2,700 | 23.47 | 63,369 |
| 2019-03-26 | Haley Patrick J. (Sr. Vice President, Commercial) | Option Ex | 2,700 | 5.18 | 13,986 |
| 2019-03-25 | Schwab Gisela (Pres, Prod Dev & Med Aff & CMO) | Sale | 100,000 | 23.14 | 2,314,000 |
| 2019-03-25 | Schwab Gisela (Pres, Prod Dev & Med Aff & CMO) | Option Ex | 100,000 | 7.18 | 718,000 |
| 2019-03-14 | Haley Patrick J. (Sr. Vice President, Commercial) | Sale | 2,000 | 25.00 | 50,000 |
| 2019-03-14 | Haley Patrick J. (Sr. Vice President, Commercial) | Option Ex | 2,000 | 1.76 | 3,520 |
| 2019-03-14 | Scangos George A | Sale | 5,000 | 25.00 | 125,000 |
| 2019-03-13 | Morrissey Michael (President and CEO) | Sale | 40,000 | 24.52 | 980,800 |
| 2019-03-13 | Morrissey Michael (President and CEO) | Option Ex | 40,000 | 5.56 | 222,399 |
| 2019-03-11 | Haley Patrick J. (Sr. Vice President, Commercial) | Sale | 959 | 23.13 | 22,181 |
| 2019-03-01 | Scangos George A | Sale | 40,000 | 22.66 | 906,400 |
| 2019-02-27 | Morrissey Michael (President and CEO) | Sale | 40,000 | 22.69 | 907,600 |
| 2019-02-27 | Morrissey Michael (President and CEO) | Option Ex | 40,000 | 5.56 | 222,399 |
| 2019-02-25 | Haley Patrick J. (Sr. Vice President, Commercial) | Sale | 4,272 | 22.27 | 95,137 |
| 2019-02-25 | Cohen Charles | Sale | 5,271 | 22.18 | 116,910 |
| 2019-02-25 | Cohen Charles | Option Ex | 26,250 | 4.37 | 114,581 |
| 2019-02-22 | Marchesi Vincent T | Sale | 41,250 | 21.50 | 886,875 |
| 2019-02-22 | Marchesi Vincent T | Option Ex | 41,250 | 4.88 | 201,423 |
| 2019-02-21 | Papadopoulos Stelios | Sale | 26,250 | 21.25 | 557,812 |
| 2019-02-21 | Papadopoulos Stelios | Option Ex | 26,250 | 4.37 | 114,581 |
| 2019-02-20 | Willsey Lance | Sale | 26,250 | 21.11 | 554,137 |
| 2019-02-20 | Willsey Lance | Option Ex | 26,250 | 4.37 | 114,581 |
| 2019-02-19 | Cohen Charles | Sale | 48,180 | 21.48 | 1,034,906 |
| 2019-02-15 | Schwab Gisela (Pres, Prod Dev & Med Aff & CMO) | Sale | 23,000 | 22.20 | 510,600 |
| 2019-02-15 | Schwab Gisela (Pres, Prod Dev & Med Aff & CMO) | Option Ex | 23,000 | 5.56 | 127,879 |
| 2019-02-15 | Cohen Charles | Sale | 100,000 | 22.19 | 2,219,000 |
| 2019-02-14 | Feldbaum Carl B | Sale | 50,500 | 22.03 | 1,112,515 |
| 2019-02-14 | Feldbaum Carl B | Option Ex | 50,500 | 5.02 | 253,661 |
| 2019-02-14 | Schwab Gisela (Pres, Prod Dev & Med Aff & CMO) | Sale | 100,000 | 21.66 | 2,166,000 |
| 2019-02-14 | Schwab Gisela (Pres, Prod Dev & Med Aff & CMO) | Option Ex | 100,000 | 5.56 | 556,000 |
| 2019-02-14 | Morrissey Michael (President and CEO) | Sale | 40,000 | 22.52 | 901,000 |
| 2019-02-14 | Morrissey Michael (President and CEO) | Option Ex | 40,000 | 5.56 | 222,399 |
| 2019-02-14 | Cohen Charles | Sale | 100,000 | 22.41 | 2,241,000 |
| 2019-02-11 | Haley Patrick J. (Sr. Vice President, Commercial) | Sale | 1,000 | 21.30 | 21,300 |
| 2019-02-01 | Scangos George A | Sale | 40,000 | 23.53 | 941,200 |
| 2019-01-30 | Morrissey Michael (President and CEO) | Sale | 40,000 | 23.12 | 924,800 |
| 2019-01-30 | Morrissey Michael (President and CEO) | Option Ex | 40,000 | 5.56 | 222,399 |
| 2019-01-16 | Morrissey Michael (President and CEO) | Sale | 40,000 | 23.60 | 944,000 |
| 2019-01-16 | Morrissey Michael (President and CEO) | Option Ex | 40,000 | 5.56 | 222,399 |
| 2019-01-10 | Haley Patrick J. (Sr. Vice President, Commercial) | Sale | 3,000 | 23.77 | 71,310 |
| 2019-01-10 | Haley Patrick J. (Sr. Vice President, Commercial) | Option Ex | 2,000 | 1.76 | 3,520 |
| 2019-01-09 | Haley Patrick J. (Sr. Vice President, Commercial) | Sale | 1,560 | 23.50 | 36,660 |
| 2019-01-09 | Haley Patrick J. (Sr. Vice President, Commercial) | Option Ex | 1,560 | 5.82 | 9,079 |
| 2019-01-08 | Haley Patrick J. (Sr. Vice President, Commercial) | Sale | 2,000 | 23.00 | 46,000 |
| 2019-01-08 | Haley Patrick J. (Sr. Vice President, Commercial) | Option Ex | 2,000 | 1.76 | 3,520 |
| 2019-01-08 | Garber Alan M | Sale | 11,250 | 23.00 | 258,750 |
Insider trading activities including stock purchases, stock sales, and option exercises of EXEL listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Exelixis, Inc. (symbol EXEL, CIK number 939767) see the Securities and Exchange Commission (SEC) website.